Dermatology

>

Latest News

FDA approves ruxolitinib for pediatric atopic dermatitis | Image Credit: Contemporary Pediatrics
FDA approves ruxolitinib for pediatric patients with atopic dermatitis aged 2 to 11 years

September 18th 2025

The FDA has approved an additional indication for Incyte's ruxolitinib cream to include pediatric patients.

EADV: Icotrokinra maintains long-term efficacy, safety for plaque psoriasis | Image Credit: © SNAB - © SNAB - stock.adobe.com.
EADV: Icotrokinra maintains long-term efficacy, safety for plaque psoriasis

September 18th 2025

FDA expands B-VEC label to include patients from birth with dystrophic epidermolysis bullosa | Image credit: Contemporary Pediatrics
FDA expands B-VEC label to include patients from birth with dystrophic epidermolysis bullosa

September 15th 2025

Emollients for diapers? Yes! Type? It doesn’t matter! | Image credit: Contemporary Pediatrics
Emollients for diapers? Yes! Type? It doesn’t matter!

September 7th 2025

Arcutis submits sNDA for roflumilast cream 0.3% for treatment of psoriasis in children 2-5 years | Image credit: Contemporary Pediatrics
Arcutis submits sNDA for roflumilast cream 0.3% for treatment of psoriasis in children 2-5 years

September 3rd 2025

Latest CME Events & Activities
<1
...
4041424344
© 2025 MJH Life Sciences

All rights reserved.